Given that drugs targeting chromatin-modifying enzymes are being explored as anticancer therapies, both alone and in combination with DNA-damaging treatments, defining the role of the USP11/NuRD complex in DDR functions will aid the effort in developing promising cancer therapeutics. Here, USP11 is linked to cancer.